Celldex Therapeutics, Inc. (CLDX) vs Vera Therapeutics, Inc. (VERA)
A side-by-side comparison of Celldex Therapeutics, Inc. and Vera Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLDX
Celldex Therapeutics, Inc.
$31.08HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
VERA
Vera Therapeutics, Inc.
$29.07HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — CLDX vs VERA
growth of $100 · dividends reinvested · last 5yCLDX +20.3% (+3.8%/yr)VERA +159.4% (+21.0%/yr)VERA compounded faster over this window
CLDX VERA
CLDX vs VERA: by the numbers
- •VERA is the larger company ($2.09B vs $2.07B market cap).
- •Both run net losses; VERA's is the smaller (0.00% vs -268385.71% net margin).
Metrics side by side
Valuation
| Metric | CLDX | VERA |
|---|---|---|
| P/S ratio | 18461.45 | N/A |
| P/B ratio | 2.89 | 5.12 |
Profitability
| Metric | CLDX | VERA |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -19160.00% | 0.00% |
| Net margin | -268385.71% | 0.00% |
| ROE | -42.07% | -98.56% |
| ROIC | -45.19% | -85.78% |
Growth (annualized)
| Metric | CLDX | VERA |
|---|---|---|
| Revenue CAGR (5Y) | -58.05% | N/A |
| Total return CAGR (5Y) | -10.28% | 14.09% |
Frequently asked
- How have CLDX and VERA total returns compared?
- Over the past 5 years, CLDX delivered -10.28% and VERA delivered 14.09% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.